Tumour excisional surgery, anaesthetic-analgesic techniques, and oncologic outcomes: a narrative review

Orla Murphy, Patrice Forget, Daqing Ma, Donal J Buggy* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Cancer is a growing global burden; there were an estimated 18 million new cancer diagnoses worldwide in 2020. Excisional surgery remains one of the main treatments for solid organ tumours in cancer patients and is potentially curative. Cancer- and surgery-induced inflammatory processes can facilitate residual tumour cell survival, growth, and subsequent recurrence. However, it has been hypothesised that anaesthetic and analgesic techniques during surgery might influence the risk of cancer recurrence. This narrative review aims to provide an updated summary of recent observational studies and new randomised controlled clinical trials on whether certain specific anaesthetic and analgesic techniques or perioperative interventions during tumour resection surgery of curative intent materially affect long-term oncologic outcomes.

Original languageEnglish
Pages (from-to)989-1001
Number of pages13
JournalBritish Journal of Anaesthesia
Volume131
Issue number6
Early online date7 Sept 2023
DOIs
Publication statusPublished - 1 Dec 2023

Keywords

  • general anaesthesia
  • intravenous anaesthesia
  • metastasis cancer
  • opioid cancer
  • postoperative analgesia
  • recurrence cancer
  • regional analgesia
  • surgery

Fingerprint

Dive into the research topics of 'Tumour excisional surgery, anaesthetic-analgesic techniques, and oncologic outcomes: a narrative review'. Together they form a unique fingerprint.

Cite this